Reports
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Salicylic acid 20% w/w in emulsifying ointment | Unlicensed specials |
||
Salicylic acid 5% w/w / propylene glycol 47.5% w/w in Dermovate® cream | Unlicensed special |
||
Salicylic acid 5% w/w in emulsifying ointment | Unlicensed special |
||
Saliva artificial spray (Saliveze) | Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, Dental practitioners |
||
Salivix® pastilles | Approved for ACBS conditions, e.g. dry mouth (xerostomia) as a result of having (or having undergone) radiotherapy, or sicca syndrome. Palliative Care, dental practitioners. |
||
Salmeterol inhaler | Prescribe by brand to ensure patients receive the device they are used to. Check licensed indication (differences among brands). Be aware of differences in excipients among the different brands- APC listing of current formulary brands |
||
Selegiline lyophisilate | For patients with swallowing difficulties only |
||
Semaglutide (Wegovy®) | The use of semaglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place. Prescribe by brand (Wegovy®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes. The Wegovy® brand of semaglutide is not commercially available yet. |
||
Sevelamer tablets | Specialist recommendation. |
||
Sildenafil injection | Hospital use only. NHS England commissioned. |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.